These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37918678)
1. Challenges of nanoparticle albumin bound (nab™) technology: Comparative study of Abraxane® with a newly developed albumin-stabilized itraconazole nanosuspension. Adick A; Hoheisel W; Schneid S; Mulac D; Azhdari S; Langer K Eur J Pharm Biopharm; 2023 Dec; 193():129-143. PubMed ID: 37918678 [TBL] [Abstract][Full Text] [Related]
2. Formulation and drying of miconazole and itraconazole nanosuspensions. Cerdeira AM; Mazzotti M; Gander B Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552 [TBL] [Abstract][Full Text] [Related]
3. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application. Pawar P; Duduskar A; Waydande S Curr Drug Res Rev; 2021; 13(1):36-48. PubMed ID: 32990554 [TBL] [Abstract][Full Text] [Related]
4. Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development. Czyz S; Wewers M; Finke JH; Kwade A; van Eerdenbrugh B; Juhnke M; Bunjes H Eur J Pharm Biopharm; 2020 Jul; 152():63-71. PubMed ID: 32376369 [TBL] [Abstract][Full Text] [Related]
5. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation. Sun W; Ni R; Zhang X; Li LC; Mao S Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575 [TBL] [Abstract][Full Text] [Related]
6. Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beads. Parmentier J; Tan EH; Low A; Möschwitzer JP Int J Pharm; 2017 May; 524(1-2):443-453. PubMed ID: 28400290 [TBL] [Abstract][Full Text] [Related]
7. Nanonized itraconazole powders for extemporary oral suspensions: Role of formulation components studied by a mixture design. Foglio Bonda A; Rinaldi M; Segale L; Palugan L; Cerea M; Vecchio C; Pattarino F Eur J Pharm Sci; 2016 Feb; 83():175-83. PubMed ID: 26742430 [TBL] [Abstract][Full Text] [Related]
8. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size. Azad M; Moreno J; Bilgili E; Davé R Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of voriconazole loaded nanoparticles for parenteral delivery. Füredi P; Kovács K; Ludányi K; Antal I; Klebovich I Int J Pharm; 2016 Aug; 510(1):159-63. PubMed ID: 27291972 [TBL] [Abstract][Full Text] [Related]
15. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118 [TBL] [Abstract][Full Text] [Related]
16. An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation. Suh MS; Patil SM; Kozak D; Pang E; Choi S; Jiang X; Rodriguez JD; Keire DA; Chen K AAPS PharmSciTech; 2020 May; 21(5):136. PubMed ID: 32419122 [TBL] [Abstract][Full Text] [Related]
17. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs. Wang Y; Miao X; Sun L; Song J; Bi C; Yang X; Zheng Y Curr Pharm Des; 2014; 20(3):454-73. PubMed ID: 23651402 [TBL] [Abstract][Full Text] [Related]
18. Conversion of nanosuspensions into dry powders by spray drying: a case study. Chaubal MV; Popescu C Pharm Res; 2008 Oct; 25(10):2302-8. PubMed ID: 18509597 [TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles. Kouchakzadeh H; Safavi MS; Shojaosadati SA Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278 [TBL] [Abstract][Full Text] [Related]
20. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology. Gajera BY; Shah DA; Dave RH Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]